by Aspirion | Nov 10, 2025 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Aspirion CEO, Nick Giannasi, shares how artificial intelligence is accelerating the company’s mission, unlocking new opportunities for healthcare revenue cycle management innovation and impact, and empowering the team to shape a transformative future together in...
by Aspirion | Nov 5, 2025 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Gloriann Sordo, General Manager of Denials Management at Aspirion, discusses the unique challenges children’s hospitals face with AI-powered claim denials and shares strategies for success. Healthcare technology is evolving rapidly, especially in claims...
by Aspirion | Oct 30, 2025 | Payment Variance Recovery, Revenue Cycle Management, Zero Balance Review
Hospital finance leaders spend countless hours focused on accounts receivable aging reports, denials management workflows, and outstanding claim balances. But some of the biggest revenue leakage is coming from accounts that have been closed. Enter the often overlooked...
by Aspirion | Oct 22, 2025 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Time literally equals money in healthcare revenue cycle management (RCM). Every day a denied claim sits unresolved is another day your hospital operates without revenue that’s rightfully yours. For most healthcare providers, the journey from denial to appeal...
by Aspirion | Oct 21, 2025 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Published in the HFMA New Jersey newsletter, Garden State Focus, Fall 2025 | Authors: Meghan Mackenzie & Tracey Flowers of Hackensack Meridian Health and Charlotte Hadland of Aspirion. The Growing Threat of DRG Downgrades Hackensack Meridian Health (HMH), along...
by Aspirion | Oct 20, 2025 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Published in the HFMA First Illinois Speaks Newsletter, October 2025 | Author: Jessica Dykstra, Client Success Director with Aspirion. The healthcare denials crisis has reached critical levels, with claim denials climbing from 10.2% in 2020 to 11.8% in 2024—a 15%...
